Rosputerbenzor announces the prevention of hepatitis B Hepatitis B is a viral disease that damages the liver and is a serious health threat. 5-10% of adults and up to 90% of children infected at birth develop a chronic form of the disease, which can lead to fibrosis, cirrhosis, and an increase in the risk of liver cancer. The virus can infect other organs. It is transmitted through blood, through sexual contact, from mother to child. Infection is possible through non-sterile instruments, for example, during tattooing, manicures and medical procedures. Hepatitis B vaccine is the first vaccine on the national calendar. This is due to the fact that the child can be infected during birth if the mother is a carrier of the virus. The probability of transmission reaches 90%. Babies' immune systems have not yet formed; 90% of children infected at birth develop a chronic form of hepatitis B. The World Health Organization recommends vaccinating all newborns in the first 24 hours of life, and children born to mothers with hepatitis B in the first 12 hours. The vaccine against hepatitis B is safe for children: the vaccine does not contain a live virus, but is created on the basis of an artificially obtained surface antigen of the virus. It cannot cause infection, but it is effective in stimulating the immune response. To create reliable immunity, you must receive three vaccines:
1. The first dose - in the first 24 hours of life, in the maternity hospital.
2. Second dose - one month after the first.
3. Third dose - 6 months after the first. After a full course of vaccination, most people develop strong immunity that lasts for many years. For children born to mothers with confirmed viral hepatitis B, an accelerated vaccination schedule is used:
1. The first dose - in the first 12 hours of life, in the maternity hospital.
2. Second dose - after a month.
3. Third dose - after two months.
4. The fourth dose, the fixative - 12 months after the first.